Testimony of Charles Halpern, Public Interest Attorney and Member, Institute of Medicine of the National Academy of Sciences
By Charles Halpern,
Testimony to California Senate Subcommittee
| 03. 09. 2005
Oversight Hearing on the Implementation of Proposition 71, the Stem Cell Research and Cures Act
Joint Hearing of the California Senate Subcommittee on Stem Cell Research Oversight, Senate Health Committee, and Assembly Health Committee
Testimony of Charles Halpern, Public Interest
Attorney and Member, Institute of Medicine of the National Academy
of Sciences
Oversight Hearing on the Implementation of Proposition 71,
the Stem Cell Research and Cures Act
Joint Hearing of the California Senate Subcommittee on Stem
Cell Research Oversight, Senate Health Committee, and Assembly
Health Committee
March 9, 2005
SUMMARY
This Oversight Hearing is an important milestone in the California
effort to assume leadership in the field of stem cell research.
Active legislative engagement with the California Institute
for Regenerative Medicine (CIRM) is essential for this initiative
to succeed.
The Independent Citizen’s Oversight Committee (ICOC) has
met four times since the passage of Proposition 71. While the
ICOC has made some important decisions, it still must lay a
solid foundation for its grants program. Grant guidelines and
an operating budget must be developed. The conflict of interest
problem, which affects all aspects of the ICOC process, must
be addressed in a serious fashion.
I encourage the Senate Oversight Subcommittee to take the following
steps:
Establish a regular schedule of oversight hearings, every two
or...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Jacob Bogage, The Washington Post | 09.03.2025
The conservative group behind the Project 2025 governing playbook for President Donald Trump’s second term is set to propose sweeping revisions to U.S. economic policy meant to encourage married heterosexual couples to have more children.
The Heritage Foundation, a right-wing...
By Caroline Kitchener, The New York Times | 08.21.2025
Less than two weeks after an Alabama Supreme Court decision upended in vitro fertilization in the state and prompted a national backlash, over 100 conservative congressional staff members and I.V.F. skeptics crammed into a meeting room a few blocks from...
By Carter Sherman, The Guardian | 08.23.2025
For Erica L and her husband, in-vitro fertilization was the “nuclear option”.
After two years of trying to conceive, Erica and her husband had no idea why they could not have a baby. Doctors said only that they had “unexplained...